Drug Shortage Report for XARELTO
| Report ID | 254942 |
| Drug Identification Number | 02378612 |
| Brand name | XARELTO |
| Common or Proper name | RIVAROXABAN |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RIVAROXABAN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90's |
| ATC code | B01AF |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2025-04-30 |
| Actual start date | 2025-04-29 |
| Estimated end date | 2025-05-15 |
| Actual end date | 2025-05-15 |
| Shortage status | Resolved |
| Updated date | 2025-05-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2025-05-15 | French | Compare |
| v20 | 2025-05-15 | English | Compare |
| v19 | 2025-05-14 | French | Compare |
| v18 | 2025-05-14 | English | Compare |
| v17 | 2025-05-13 | French | Compare |
| v16 | 2025-05-13 | English | Compare |
| v15 | 2025-05-09 | French | Compare |
| v14 | 2025-05-09 | English | Compare |
| v13 | 2025-05-02 | French | Compare |
| v12 | 2025-05-02 | English | Compare |
| v11 | 2025-04-30 | English | Compare |
| v10 | 2025-04-29 | French | Compare |
| v9 | 2025-04-29 | English | Compare |
| v8 | 2025-04-28 | French | Compare |
| v7 | 2025-04-28 | English | Compare |
| v6 | 2025-04-23 | French | Compare |
| v5 | 2025-04-23 | English | Compare |
| v4 | 2025-04-17 | French | Compare |
| v3 | 2025-04-17 | English | Compare |
| v2 | 2025-04-11 | French | Compare |